Based on our analyses, CM from CD248+CAFs or from CAFs‐sh‐CD248 with IL‐8 supplementation, and not from CAFs‐sh‐CD248, robustly protected cancer cell lines from chemotherapy‐triggered apoptosis (Figure 3C,D). Here, CXCL8 is linked to cancer.